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Summary
Objectives The aim of this study was to examine a cohort of patients
who had suffered an arterial embolism to see whether a patent foramen
ovale (PFO) was an identiﬁable cause.
Design This study was conducted in two parts; a retrospective limb
involving an audit of patient records over a period of 10 years, and a
prospective limb including selected patients from that audit to search for a
PFO using an agitated saline test with transcranial Doppler ultrasound
monitoring of the anterior cerebral artery. Data on patients with peripheral
vascular disease were collected using a structured questionnaire.
Setting A clinical vascular department. All patients were seen in the
vascular outpatients clinic.
Participants Patients who had been identiﬁed from a retrospective
search based on the headline diagnosis of arterial embolus. Collected data
on the 71 patients revealed that 75% had predisposing factors for DVT,
70% were male smokers, and 84.4% had a signiﬁcant past history of
vascular symptoms.
Main outcome measures Whether or not patients identiﬁed as
having a possible PFO actually had one on objective testing with
transcranial Doppler assessment of the cerebral circulation with an
agitated saline solution.
Results Fifteen patients who were suspected of having a PFO were
selected from these 71 patients; 12 of these were found to have no PFO on
testing, and three had already undergone a percutaneous PFO closure.
Conclusion The incidence of a PFO in this small study group is no
higher than that found in the general population (3/15, 20%). There was
high prevalence of male smokers with associated predisposing factors
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1Introduction
A patent foramen ovale (PFO) is an inter-atrial
communication recognized since the time of
Galen.
1,2 In 1564 Botallo described the presence
of a PFO at birth,
1–3 and it is still sometimes
referred to as the foramen of Botallo.
1,2 In 1877
Cornheim described a paradoxical embolus
related to a PFO.
1,2 Patients with a PFO have
speciﬁc characteristic clinical and ECG ﬁndings
which may sometimes be altogether absent.
2
There may be an ejection systolic murmur, there
may be ﬁxed splitting of the second heart sound,
and there may be non-speciﬁc ﬁndings of right
heart failure. The ECG may reveal a prolonged
PR interval, occasional atrial ﬁbrillation and,
most speciﬁcally, incomplete right bundle branch
block. Some patients may present with a history
of stroke or a transient ischaemic event of un-
deﬁned aetiology.
1,2
The foramen ovale is a slit-like opening in the
atrial septum at the site of the foramen secundum
oftheseptumprimum.Theleftatrialpressurerises
shortly after birth and the ﬂap is lightly pressed
against the septum secundum and closes the
foramen ovale functionally.
2 Patency of the PFO
has been identiﬁed as a potential risk factor for
paradoxical embolism potentially followed by cer-
ebral or peripheral ischaemic events.
4 Although
theunderlyingmechanismbywhichPFOaccounts
for the phenomenon is not entirely clear, the trans-
septal passage of emboli from the right to the left-
sided chambers of the heart appear to play an
important role.
4,5 Moreover, 4.2% of patients with
a documented PFO and previous embolism are at
increased risk of recurrent thromboembolic
events even under therapeutic anticoagulation.
4
Hoffman et al. suggested that anatomic patency
may persist for several months after birth and 50%
of all infants have a probe-patent PFO at the end of
the ﬁrst year of life,
2 and although this ﬁgure falls
with age, 30% of the adult population probably
have a PFO.
Ordinarily, a left-to-right shunt will cause no
problems, but a right-to-left shunt, if large
enough, will cause a low arterial O2 tension
(hypoxia) and severely limited exercise capacity.
In deep-sea divers there is a risk of paradoxical
embolism of gas bubbles (passage of bubbles
into the arterial circulation) which form in the
majority of divers in the venous circulation
during decompression. Blood can ﬂow in both
directions within intra-atrial shunts at various
phases of the cardiac cycle and some experts feel
that a large atrial septal defect or PFO is a contra-
indication to diving.
The average size of a PFO increases from a
mean of 3.4 mm in the ﬁrst decade to 5.8 mm in
the 10th decade of life.
1,2,4 The larger the degree
of inter-atrial shunting, the greater the incidence
of subsequent transient ischaemic attack or
stroke.
1,2 Depending on the criteria used for diag-
nosis and the technology used for cardiac assess-
ment, the prevalence of PFO in the healthy
population is approximately 20–25%.
6,7 On the
basis of prevalence, it is estimated that approxi-
mately 60–70 million Americans have a PFO.
8
Thus the detection of a PFO during the evaluation
of a patient with stroke is not a surprising ﬁnding
and the frequency of PFO detection in these
patients can be as high as 40–45%.
9,10 PFO is
now detected in 10–15% of the normal population
using contrast echocardiography. Postmortem
studies in otherwise normal hearts have shown a
high (27%) prevalence of PFO. The prevalence
found in autopsies among stroke patients is even
higher (40%).
2,11,12
With increasing evidence that a PFO is the
culprit in paradoxical embolic events, paradoxical
embolism through a PFO should be strongly sus-
pected in a young patient with cryptogenic
stroke and the relative importance of PFO is
being re-evaluated.
1,13,14 The clinical diagnosis of
paradoxical embolism is almost always presump-
tive and is suspected in patients who have a
venous thrombus, a right-to-left shunt and evi-
dence of arterial embolism.
15 A deﬁnite diagnosis
of paradoxical embolism is established when a
thrombus is seen traversing the shunt.
15 Deep
venous thromboses are found with variable
success in patients suspected of paradoxical
embolism, and the prevalence of DVT ranges
from 9.5% to 88% depending on the timing and
methods used for diagnosis.
15
It was documented in a recent investigation
that the prevalence of a right-to-left shunt was sig-
niﬁcantly higher in patients suffering from
migraine with aura than in healthy controls and
similar to that found in young patients with
stroke.
16,17 A recent study revealed that a
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Arthur Tuckerright-to-left shunt can occur through a PFO in sub-
jects with obstructive sleep apnoea syndrome
during periods of nocturnal apnoea if the
apnoea length is longer than 17 seconds.
18,19
Echocardiography is a necessary tool for the
diagnosis of PFO, which can be diagnosed by
the use of eithercolour ﬂow Doppleroran intrave-
nous agitated saline contrast study. This is per-
formed after obtaining optimal visualization of
the atrial septum using transthoracic or if necess-
ary, trans-oesophageal echocardiography.
1,20 A
trans-oesophageal echo provides better visualiza-
tion of the atrial septum and is therefore more sen-
sitive than trans-thoracic echo for detecting PFO,
but it is signiﬁcantly more invasive and unplea-
sant for the patient.
1,21
Bilateral transcranial Doppler ultrasound
(TCD) can be used to assess a right-to-left shunt,
by monitoring both middle cerebral arteries
during normal ventilation and during a Valsalva
manoeuvre according to the Consensus Meeting
of the European Society of Neurology.
16 The tech-
nique used is described below.
Right-to-left shunting is graded in consensus
by an experienced cardiologist and radiologist as
follows: Grade 0 – no contrast agent passed
from the right to the left atrium; Grade 1 – 3–9
microbubbles passed from the right to the left
atrium; Grade 2 –10–29; and Grade 3 – >30
microbubbles.
22,23 In 76 healthy volunteers, a
trans-thoracic echocardiographic study using a
well established, agitated saline contrast tech-
nique found that the prevalence of right-to-left
shunting through a PFO was 5% when subjects
were at rest and 18% when subjects performed a
Valsalva manoeuvre.
6
When a PFO is found in association with an
otherwise unexplained neurological event, there
is general agreement that the patient should be
treated with anticoagulation, and in some cases
that the PFO should be closed. Medical treatment
consists of the administration of warfarin with or
without aspirin to prevent stroke recurrence. Sur-
gical PFO closure using double continuous
suture results in no recurrence of neurological
events during a follow-up period of 1–4 years
but it requires a thoracotomy and cardiopulmon-
ary bypass.
24,25 Percutaneous closure using a
deployable device manoeuvred into the PFO




Data were collected retrospectively over a 10-year
period from 1996 to 2006 from patient records at
the London Chest Hospital, Royal London Hospi-
tal and St Bartholomew’s Hospital. Patients with
arterial emboli were identiﬁed using this headline
diagnosis given on the hospital computer data-
base. Medical records were obtained and were
then studied in more detail using a notes question-
naire which included questions about the main
presenting complaint (such as peripheral arterial
embolus or stroke), whether there was a predis-
posing factor for DVT, a congenital cardiac
abnormality, and a past history of bleeding dis-
order, liver disease, previous stroke or diabetes.
The existence of previous investigations such as
aC T /MRI scan, transcranial Doppler, trans-
oesophageal echo (TOE) or a duplex scan for a
DVT and most importantly if a transcranial
Doppler test with agitated saline was carried out
to identify a right-to-left shunt was also recorded.
Based on the above information 15 patients
were identiﬁed from the original 71 and some of
these were examined in more detail as a prospec-
tive study. Seventy-one patients were found to
have had an arterial embolus, and 15 of these
were thought from the clinical ﬁndings to have a
PFO.
All patients diagnosed with peripheral arterial
embolism, thrombosis, and stroke of undeter-
mined origin, on the basis of the above clinical
ﬁndings and investigations, were considered in
this study. An agitated saline test with transcranial
Doppler ultrasound was carried out on those
patients in whom a right-to-left shunt was sus-
pected. Patients aged under 15 years, patients
with acquired cardiac disease, and patients with
known congenital heart disease were excluded.
Transcranial Doppler protocol
The transcranial Doppler
1 and agitated saline test
was performed in outpatients using a standard
protocol with written informed consent. Agitated
saline was injected via an arm vein and the
middle cerebral artery was insonated during a
Valsalva manoeuvre. If a microbubble storm was
detected the study was deemed positive. The
process involves the study of blood ﬂow in the
middle cerebral artery prior to and after a
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3peripheral venous injection of agitated saline. A
cannula is placed in an antecubital vein and con-
nected to a three-way tap which connects two
10 mL syringes, one of which contains normal
saline and the other of which contains air. The
air and the saline are mixed by vigorous alternate
movements of the plunger of each syringe and
when the saline is full of microbubbles the three-
way tap is adjusted and the saline is injected into
the circulation.
The patient performs the Valsalva manoeuvre
(VM) for 5 s, i.e. forced expiration against a
closed glottis. The middle cerebral artery is
located using a 2 MHz ultrasound probe. Record-
ings commence at baseline, followed by two
further recordings during the VM or during
coughing. The ﬁrst recording is done at baseline
followed by two further recordings during VM
or coughing. The test is positive if a microbubble
storm is detected during any of the recordings.
This process is outlined below:
￿ Time 0–3 s: 10 mL agitated saline is injected;
￿ Time 5 s: patient performs a VM/coughing
manoeuvre for 5 s;
￿ Time 3–40 s: observation for microbubbles,
which if noted, the test is positive and
complete;
￿ Time 120 s: if no microbubbles, the test is nega-
tive and complete.
Transcranial Doppler (TCD) with agitated saline
testing has been shown to be more sensitive than
echocardiography imaging in order to detect the
presence of a right-to-left shunt.
27 TCD has been
reported to have a 92.85% sensitivity and 82.35%
speciﬁcity as compared to transthoracic echocar-
diography for the diagnosis of PFO.
28
Results
An initial search of records based on the term
‘paradoxical embolus’ generated a list of about
900 patients. A reﬁned search of these records
using the search term ‘peripheral arterial embo-
lism’ generated a shorter list of about 450
records. Combining the search terms ‘right to
left shunt’ and ‘peripheral arterial embolism’
cut the number of records down to 71, and 15
of these were thought likely to have a PFO,
based on a ﬁltering questionnaire applied to the
notes. Of the remaining 15 patients, three had pre-
viously had a PFO closed using a percutaneous
device.
The original 71 patients were analysed for epi-
demiological data on the aetiology of arterial
embolus.
Of the 15 patients selected from the original 71
thought to have a PFO, the 12 who had not had a
closure device ﬁtted were invited to attend an out-
patient clinic for an agitated saline test. In this
study, only ﬁve patients could be traced and
studied. This formed the prospective part of the
study.
Retrospective data results
Of the initial 71 patients, 44 were men and 27
were women. The mean age was 65.1 years. One
of the patients was a scuba diver. The commonest
site for an embolus was in the leg (38) followed by
the foot (9) and the arm (6). There was only one
stroke.
The duration of symptoms varied; 13 patients
had been suffering for less than a week, 14 for
between a week and a month, and 41 for more
than a month. Two patients were not documented.
A higher percentage of the patients had a recur-
rence of signs and symptoms and around 34%
had no recurrence after treatment given.
There were a number of predisposing factors
which included recent surgery (16), hypercoagul-
ability (14), immobilization (12) and previous
DVT (10). No predisposing factor could be found
in 20 patients; 75% had an identiﬁable predispos-
ing factor.
Twenty-one percent had a history of diabetes
mellitus and 7% had had a stroke; 67.6% of the
selected patients were smokers and 38% con-
sumed alcohol – there was no clear record of the
amounts; 57.7% of the patients had undergone
tests for a hypercoagulable state.
Thirty-two patients underwent an investigation
to rule out DVT; this consisted of a duplex ultra-
sound in all patients, with an additional Veno-
gram if the results were equivocal; 23.9 % of the
patients had this done within 7 days, two
between 8–10 days and ﬁve after 10 days. The
majority underwent an angiogram or an angio-
plasty. Nine percent of the patients underwent a
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4TOE. Around4% had atranscranial Doppler,ECG,
arterial duplex scan and angiogram.
As far as treatment is concerned, 50% under-
went surgical treatment for removal of the
embolus, 30% were treated conservatively and
17% were treated conservatively initially and
then proceeded to surgery. There was one death
reported
Prospective data results
From the 71 patients included in the study as
having suffered a peripheral arterial embolus, 15
were selected because they were thought to have
a right-to-left shunt. These were seen as outpati-
ents and a transcranial Doppler agitated saline
test was carried out. Only ﬁve of the 15 patients
were available for this investigation. Three had
already had a percutaneous closure of PFO and
seven were not contactable. The test procedure
was explained and consent was taken. The test
result was documented on a standardized form.
All ﬁve tests were negative and no right-to-left
shunts were found.
Discussion
Statement of principal ﬁndings
The incidence of a PFO in this small study group
was found to be no higher than that found in the
general population (3/15, 20%). There was a high
prevalence of male smokers with associated pre-
disposing factors leading to a DVT. Seventy-ﬁve
percent of patients had predisposing factors for
DVT, 70% were male smokers and 84.4% had a sig-
niﬁcant past history of vascular symptoms. The
study showed that PFO may not be a major or
direct cause of paradoxical embolism, even
though there is direct evidence dating back to
1877 that this might be the case.
29
Strengths and weaknesses of the study
The main advantage of this study was that com-
prehensive data was collected over a 10-year
period from 1996 to 2006 and appropriate patients
were identiﬁed after detailed scrutiny. Informed
consent was obtained and agitated saline testing,
which is a sensitive test that provides rapid
results in a minimally-invasive and cost-effective
manner. The major weakness of this study is the
fact that a very small sample size was obtained.
This does in fact suggest that the numberof symp-
tomatic PFOs compared with the total number in
the population is small, and this is discussed
below.
Strengths and weaknesses in relation to
other studies
Many studies show that there is a high prevalence
of PFO in approximately one-quarter of the
general population.
30 Age does not play much of
a role in the formation of an embolus and is not
a predictorof PFO in patients with cerebral ischae-
mic events.
11 In the present study the mean age
was 65.1 years and none of them were found to
have a PFO (RLS). The three patients who we
reviewed who had already had PFO closures
were all below 55 years of age. Also there have
been studies showing that ASA and PFO are fre-
quently observed with cerebral ischaemic events
especially in patients who are under 55 years
old.
31,32
Paradoxical embolism through a PFO is a
recognized cause of stroke.
23,33 In our small
study, very few patients had suffered a properly
diagnosed stroke. A study from Minnesota,
USA
34 concluded that ‘Patent foramen ovale is
not a risk factor for cryptogenic ischaemic stroke
or transient ischaemic attack in the general
population’.
There was one occupational scuba diver
included in our study, though he did not show
any signs of PFO. There are studies which show
that PFO increases the risk for decompression
illness by a factor of up to ﬁve times due to the
increase in intrathoracic pressure.
35–37 These sub-
jects should minimize the load of tissue nitrogen
during dives or if this is not possible they should
give up diving.
37
There has been much debate on the ideal inves-
tigation to rule out a PFO or other right-to-left
shunt. Contrast transoesophageal echo, a semi-
invasive technique, has been regarded as the
gold standard for the detection of PFO.
38,39 In
the present study 9% of the patients underwent
TOE. Doppler, TTE and TOE with agitated saline
contrast were performed on just one patient.
Recent studies show that c-TTE with second
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5harmonic imaging and c-TOE are equivalent in
sensitivity.
39–41 The same study showed that
c-TOE was not perfect for the diagnosis as seda-
tion is used, hindering the Valsalva manoeuvre;
24
which is a safe and useful technique for the detec-
tion of a PFO.
42
Contrast transcranial Doppler (c-TCD) has been
found to be very sensitive in the detection of a
RLS,
39 and when compared to c-TOE its sensitivity
appears to be high.
39,43,44 In the present study we
found around 7% who had had a simple TCD
and 12 patients were selected on whom a TCD
with agitated saline was carried out. One study
showed that it was as sensitive as c-TOE.
45,46
Meaning of the study: possible
mechanisms and implications for
clinicians or policymakers
This small study showed that a PFO may not be a
major cause for patients who have suffered an
arterial embolism. It also showed that male
smokers probably have a higher incidence of para-
doxical embolism in the lower limbs with predis-
posing factors leading to a DVT.
An embolus can be found anywhere in the cir-
culatory tree but half the patients in the present
study had a leg embolus. Sixty-three percent of
patients had recurrence of symptoms which
suggests that regular check-ups are necessary
and deﬁnite treatment, either medical or surgical,
is necessary.
Many had predisposing factors for DVT, such
as a hypercoagulable state or recent surgery. It is
presumed that the mechanism for PFO-related
systemic ischaemic events is paradoxical emboli-
zation of thromboembolic fragments originating
from the venous tree.
47 Hence paradoxical embo-
lism could be a risk of DVT. Deep venous throm-
bosis was detected in nearly 10% of patients
with PFO as the sole identiﬁable cardiac risk
factor and it was suggested that phlebography
should be performed in patients with medium or
large interatrial shunts if a paradoxical embolism
is suspected.
48
It was found in the present study that 68% of
our patients were smokers and around 40% of
the patients drank alcohol. Smoking, diabetes mel-
litus and a positive family history are all moderate
risk factors for venous thromboembolism.
49
A positive ﬁnding of the signs of postphlebitic
limb is often found on examination and here
85% of our patients exhibited this. Investigations
for thrombophilia should be carried out and in
our retrospective study of 71 patients we found
that only half of the patients had undergone this
investigation.
Of the 71 patients in the retrospective study
one-quarter were treated medically and half
were treated surgically while 17% had both
forms of treatment. One patient died before treat-
ment could be started. Percutaneous closure of
PFO is a minimally invasive procedure, safe, effec-
tive in the prevention of recurrent strokes, avoid-
ing lifelong anticoagulants and also cures
migraine to some extent.
26
Future proposals
The conclusion of the present study was a negative
result; PFO may not be a major cause of undiag-
nosed paradoxical arterial embolism; the inci-
dence of PFO in our patients was the same as in
the general population.
Future studies in the form of large prospective
multicentre trials are required which would
involve the investigation of all arterial embolus
patients attending an Emergency Department for
the presence of a right-to-left shunt.
Conclusions
There is a suggestion that the incidence of PFO
(right-to-left shunt) in patients with peripheral
arterial embolism is increased, but the results of
our small study show that the incidence is much
the same as it is in the general population. There-
fore, it appears that PFO may not be a major cause
of undiagnosed peripheral arterial embolism.
Our results conform to the accepted incidence
of PFO at an estimated percentage of 25–
30%
2,29,33 in the general population.
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